Linden Thomas Advisory Services, LLC
- SEC CIK
- 0001965702
- Latest filing
- Jul 16, 2026
DNLI holding history
Denali Therapeutics Inc. in every 13F filed by Linden Thomas Advisory Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −19,597−100.0% | Sold out | Holders |
| Q2 2023 | 19,597 | $578.3K | 0.1% | +372+1.9% | Added | Holders |
| Q1 2023 | 19,225 | $443.0K | 0.1% | +961+5.3% | Added | Holders |
| Q4 2022 | 18,264 | $507.9K | 0.1% | – | No prior filing | Holders |